Position in RYTM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,697,310
-$24,625,890 QoQ
Shares Held
123,000
-62.7% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Opaleye Management Inc. holds $427,835,777 across 44 Biotechnology names. RYTM ranks #15 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLGL |
Sol-Gel Technologies Ltd.
|
500,000 | $39,610,000 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
390,000 | $32,826,300 | |
| 3 | IRON |
Disc Medicine, Inc.
|
421,000 | $26,918,740 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,430,000 | $25,711,400 | |
| 5 | CBIO |
Crescent Biopharma, Inc.
|
1,312,615 | $24,112,737 | |
| 6 | STOK |
Stoke Therapeutics, Inc.
|
700,000 | $22,792,000 | |
| 7 | RZLT |
Rezolute, Inc.
|
6,300,000 | $19,215,000 | |
| 8 | MGTX |
MeiraGTx Holdings plc
|
2,123,259 | $18,387,422 |
All Filings in RYTM
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,697,310 | 123,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,323,200 | 330,000 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $46,627,083 | 461,700 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,015,250 | 475,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $25,955,300 | 490,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $27,990,000 | 500,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $26,195,000 | 500,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,145,900 | 515,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,314,950 | 515,000 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $28,041,700 | 610,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,970,025 | 653,000 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $12,120,150 | 735,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,112,400 | 735,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,403,200 | 735,000 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $19,845,000 | 810,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,502,300 | 362,000 | Shares | Sole | 2022-08-15 | |
| 2020-12-31 | $3,418,950 | 115,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||